Musk’s reported drug use is new headache for Tesla's board

Tesla chairwoman Robyn Denholm — Tesla Chairwoman Robyn Denholm (BLOOMBERG/Bloomberg)

By:

CRAIG TRUDELL and DANA HULL

By:

Bloomberg

January 08, 2024 11:31 AM

Elon Musk’s reported drug use has Tesla Inc. board members facing a familiar quandary: having to decide what, if anything, to do about the CEO subjecting directors and shareholders alike to great financial and legal risk.

Featured Stories

Stacking tariffs add costs and uncertainty for auto suppliers

March-Q1 U.S. auto sales: Key takeaways as tariffs neared

Trade war casualty: Volvo to drop China-made S90 in U.S., cut incentives

Motorists want to be supported by tech, not nagged, according to new survey

Latest News

U.S. Senate version of ‘right to repair’ bill introduced

Stacking tariffs add costs and uncertainty for auto suppliers

GM to lay off 200 workers at all-EV plant as it adjusts production

Audi’s top-selling crossover expected to be unsellable in U.S. after Trump tariffs

Staying current is easy with newsletters delivered straight to your inbox.

See More in Executives

GM CEO Mary Barra, Hyundai Executive Chair Euisun Chung to keynote Automotive News Congress Sept. 11

From the Newsroom: Inside Hyundai’s U.S. EV factory as tariffs shake up the auto industry

Nikola founder Trevor Milton pardoned by Trump after fraud conviction

Nissan’s next CEO Ivan Espinosa opens up on what makes him tick

Staying current is easy with newsletters delivered straight to your inbox.